Overview

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Status:
RECRUITING
Trial end date:
2027-07-30
Target enrollment:
Participant gender:
Summary
This is a prospective clinical study to evaluate the safety and efficacy of R-CMOP in patients with newly diagnosed diffuse large B-cell lymphoma
Phase:
PHASE1
Details
Lead Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Treatments:
Cyclophosphamide
Prednisolone
Rituximab
Vincristine